Search research articles
Contact Us
Filters
Showing results (641-650 of 709) with videos related to
Page
of 71
Sort By:
The Lancet. Oncology
|
March 21, 2018
Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial
Rui-Hua Xu, Kei Muro, Satoshi Morita, et al.
Targeted Oncology
|
January 9, 2024
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer
Yu Sunakawa, Yasutoshi Kuboki, Jun Watanabe, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
September 3, 2025
Aspirin-Free Prasugrel Monotherapy After Percutaneous Coronary Intervention in Patients With Non-ST Elevation Acute Coronary Syndrome
Kotaro Miyashita, Takashi Muramatsu, Pruthvi C Revaiah, et al.
Asiaintervention
|
March 20, 2023
Reduced-dose prasugrel monotherapy without aspirin after PCI with the SYNERGY stent in East Asian patients presenting with chronic coronary syndromes or non-ST-elevation acute coronary syndromes: rationale and design of the ASET Japan pilot study
Shinichiro Masuda, Takashi Muramatsu, Yuki Ishibashi, et al.
British Journal of Cancer
|
March 4, 2023
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial
Yasutoshi Kuboki, Tetsuji Terazawa, Toshiki Masuishi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 11, 2022
Carbon-ion radiotherapy versus radiofrequency ablation as initial treatment for early-stage hepatocellular carcinoma
Naoto Fujita, Naoya Kanogawa, Hirokazu Makishima, et al.
International Cancer Conference Journal
|
April 3, 2026
Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinoma
Haruka Anzai, Chihiro Miwa, Sadahisa Ogasawara, et al.
Circulation. Cardiovascular Interventions
|
July 8, 2026
Optical Coherence Tomography Characterization of Coronary Lithotripsy Following Atherectomy for Treatment of Severely Calcified Lesions
Yohei Sotomi, Nehiro Kuriyama, Yutaka Tanaka, et al.
Liver Cancer
|
March 27, 2025
Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy
Masanori Inoue, Sadahisa Ogasawara, Kazufumi Kobayashi, et al.
Cardiovascular and Interventional Radiology
|
May 30, 2024
Twenty-Four-Month Safety and Effectiveness of TCD-17187 Drug-Coated Balloon for Treatment of Atherosclerotic Lesions in Superficial Femoral and Proximal Popliteal Artery
Yoshimitsu Soga, Osamu Iida, Shu-Ichi Seki, et al.
Page
of 71
Search research articles
Search
Showing results (641-650 of 709) with videos related to
Sort By:
Page
of 71
The Lancet. Oncology
|
March 21, 2018
Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial
Rui-Hua Xu, Kei Muro, Satoshi Morita, et al.
Targeted Oncology
|
January 9, 2024
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer
Yu Sunakawa, Yasutoshi Kuboki, Jun Watanabe, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
September 3, 2025
Aspirin-Free Prasugrel Monotherapy After Percutaneous Coronary Intervention in Patients With Non-ST Elevation Acute Coronary Syndrome
Kotaro Miyashita, Takashi Muramatsu, Pruthvi C Revaiah, et al.
Asiaintervention
|
March 20, 2023
Reduced-dose prasugrel monotherapy without aspirin after PCI with the SYNERGY stent in East Asian patients presenting with chronic coronary syndromes or non-ST-elevation acute coronary syndromes: rationale and design of the ASET Japan pilot study
Shinichiro Masuda, Takashi Muramatsu, Yuki Ishibashi, et al.
British Journal of Cancer
|
March 4, 2023
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial
Yasutoshi Kuboki, Tetsuji Terazawa, Toshiki Masuishi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 11, 2022
Carbon-ion radiotherapy versus radiofrequency ablation as initial treatment for early-stage hepatocellular carcinoma
Naoto Fujita, Naoya Kanogawa, Hirokazu Makishima, et al.
International Cancer Conference Journal
|
April 3, 2026
Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinoma
Haruka Anzai, Chihiro Miwa, Sadahisa Ogasawara, et al.
Circulation. Cardiovascular Interventions
|
July 8, 2026
Optical Coherence Tomography Characterization of Coronary Lithotripsy Following Atherectomy for Treatment of Severely Calcified Lesions
Yohei Sotomi, Nehiro Kuriyama, Yutaka Tanaka, et al.
Liver Cancer
|
March 27, 2025
Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy
Masanori Inoue, Sadahisa Ogasawara, Kazufumi Kobayashi, et al.
Cardiovascular and Interventional Radiology
|
May 30, 2024
Twenty-Four-Month Safety and Effectiveness of TCD-17187 Drug-Coated Balloon for Treatment of Atherosclerotic Lesions in Superficial Femoral and Proximal Popliteal Artery
Yoshimitsu Soga, Osamu Iida, Shu-Ichi Seki, et al.
Page
of 71